Ultra-low PSA Control

The Acusera Ultra Low PSA Control is designed for the quantitative determination of low-level Prostate Specific Antigen (PSA) in human serum and plasma.

Featuring a clinically relevant concentration of approximately 0.055 ng/mL, this assayed quality control supports reliable performance monitoring at the low PSA levels important for sensitive testing.

• Liquid ready-to-use.
• Human-based material.
• Assayed target values provided.
• Optimised for use with Roche systems.
• Suitable for use across a variety of other platforms.
• 30-day open-vial stability at 2–8°C.